Accuracy of transbronchial biopsy as a rebiopsy method for patients with relapse of advanced non-small-cell lung cancer after systemic chemotherapy

von Ishii, Hidenobu, Azuma, Koichi, Yamada, Kazuhiko, Matsuo, Norikazu, Nakamura, Masayuki, Tokito, Takaaki, Kinoshita, Takashi, Hoshino, Tomoaki
Veröffentlicht in BMJ Open Respir Res (2017)

Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples

von Ishii, Hidenobu, Azuma, Koichi, Sakai, Kazuko, Kawahara, Akihiko, Yamada, Kazuhiko, Tokito, Takaaki, Okamoto, Isamu, Nishio, Kazuto, Hoshino, Tomoaki
Veröffentlicht in Oncotarget (2015)

Sarcomatoid Type Primary Pericardial Mesothelioma with a Long-term Survival after the Onset of Cardiac Tamponade

von Saisho, Chika, Ishii, Hidenobu, Edakuni, Nobutaka, Imamura, Yohei, Tokito, Takaaki, Kinoshita, Takashi, Azuma, Koichi, Yamada, Kazuhiko, Hoshino, Tomoaki
Veröffentlicht in Intern Med (2016)

Prognostic Value of Serum Tumor Markers in Patients With Stage III NSCLC Treated With Chemoradiotherapy

von TOKITO, TAKAAKI, AZUMA, KOICHI, YAMADA, KAZUHIKO, NAITO, YOSHIKO, MATSUO, NORIKAZU, ISHII, HIDENOBU, NATORI, HIROKI, KINOSHITA, TAKASHI, HOSHINO, TOMOAKI
Veröffentlicht in In Vivo (2019)

Determination of Somatic Mutations and Tumor Mutation Burden in Plasma by CAPP-Seq during Afatinib Treatment in NSCLC Patients Resistance to Osimertinib

von Ishii, Hidenobu, Azuma, Koichi, Sakai, Kazuko, Naito, Yoshiko, Matsuo, Norikazu, Tokito, Takaaki, Yamada, Kazuhiko, Hoshino, Tomoaki, Nishio, Kazuto
Veröffentlicht in Sci Rep (2020)

Programmed cell death-ligand 1 expression and immunoscore in stage II and III non-small cell lung cancer patients receiving adjuvant chemotherapy

von Ishii, Hidenobu, Azuma, Koichi, Kawahara, Akihiko, Matsuo, Norikazu, Tokito, Takaaki, Kinoshita, Takashi, Yamada, Kazuhiko, Sasada, Tetsuro, Akiba, Jun, Hoshino, Tomoaki
Veröffentlicht in Oncotarget (2017)

Predictive value of CD73 expression for the efficacy of immune checkpoint inhibitors in NSCLC

von Ishii, Hidenobu, Azuma, Koichi, Kawahara, Akihiko, Kinoshita, Takashi, Matsuo, Norikazu, Naito, Yoshiko, Tokito, Takaaki, Yamada, Kazuhiko, Akiba, Jun, Hoshino, Tomoaki
Veröffentlicht in Thorac Cancer (2020)

Phase I study of afatinib plus bevacizumab in patients with advanced non-squamous non-small cell lung cancer harboring EGFR mutations

von Ko, Ryo, Shukuya, Takehito, Imamura, Chiyo K., Tokito, Takaaki, Shimada, Naoko, Koyama, Ryo, Yamada, Kazuhiko, Ishii, Hidenobu, Azuma, Koichi, Takahashi, Kazuhisa
Veröffentlicht in Transl Lung Cancer Res (2021)

Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients

von Matsuo, Norikazu, Azuma, Koichi, Sakai, Kazuko, Hattori, Satoshi, Kawahara, Akihiko, Ishii, Hidenobu, Tokito, Takaaki, Kinoshita, Takashi, Yamada, Kazuhiko, Nishio, Kazuto, Hoshino, Tomoaki
Veröffentlicht in Sci Rep (2016)

Pulmonary pleomorphic carcinoma: A case harboring EGFR mutation treated with EGFR‐TKIs

von Masuda, Ken, Tokito, Takaaki, Azuma, Koichi, Yanagida, Eriko, Nakamura, Masayuki, Naito, Yoshiko, Matsuo, Norikazu, Ishii, Hidenobu, Yamada, Kazuhiko, Akiba, Jun, Hoshino, Tomoaki
Veröffentlicht in Thorac Cancer (2018)

The characteristics of nivolumab-induced colitis: an evaluation of three cases and a literature review

von Yamauchi, Ryosuke, Araki, Toshihiro, Mitsuyama, Keiichi, Tokito, Takaaki, Ishii, Hidenobu, Yoshioka, Shinichiro, Kuwaki, Kotaro, Mori, Atsushi, Yoshimura, Tetsuhiro, Tsuruta, Osamu, Torimura, Takuji
Veröffentlicht in BMC Gastroenterol (2018)

Lung Cancer with a Small Cell Carcinoma Component Diagnosed from Pleural Effusion and a Squamous Cell Carcinoma Component Diagnosed from the Tumor

von Zaizen, Yoshiaki, Tokito, Takaaki, Masuda, Ken, Azuma, Koichi, Naito, Yoshiki, Tsuneyoshi, Shingo, Sakazaki, Yuki, Matsuo, Norikazu, Ishii, Hidenobu, Yamada, Kazuhiko, Akiba, Jun, Hoshino, Tomoaki
Veröffentlicht in Intern Med (2018)

A Phase 2 Study of Atezolizumab for Pretreated NSCLC With Idiopathic Interstitial Pneumonitis

von Ikeda, Satoshi, Kato, Terufumi, Kenmotsu, Hirotsugu, Ogura, Takashi, Iwasawa, Shunichiro, Sato, Yuki, Harada, Toshiyuki, Kubota, Kaoru, Tokito, Takaaki, Okamoto, Isamu, Furuya, Naoki, Yokoyama, Toshihide, Hosokawa, Shinobu, Iwasawa, Tae, Yamanaka, Takeharu, Okamoto, Hiroaki
Veröffentlicht in J Thorac Oncol (2020)

Real‐world outcomes of chemoradiotherapy for unresectable Stage III non‐small cell lung cancer: The SOLUTION study

von Horinouchi, Hidehito, Atagi, Shinji, Oizumi, Satoshi, Ohashi, Kadoaki, Kato, Tomohiro, Kozuki, Toshiyuki, Seike, Masahiro, Sone, Takashi, Sobue, Tomotaka, Tokito, Takaaki, Harada, Hideyuki, Maeda, Tadashi, Mio, Tadashi, Shirosaka, Ikue, Hattori, Kana, Shin, Eisei, Murakami, Haruyasu
Veröffentlicht in Cancer Med (2020)

Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study

von Sakai, Hiroshi, Morise, Masahiro, Kato, Terufumi, Matsumoto, Shingo, Sakamoto, Tomohiro, Kumagai, Toru, Tokito, Takaaki, Atagi, Shinji, Kozuki, Toshiyuki, Tanaka, Hiroshi, Chikamori, Kenichi, Shinagawa, Naofumi, Takeoka, Hiroaki, Bruns, Rolf, Straub, Josef, Schumacher, Karl Maria, Paik, Paul K
Veröffentlicht in Jpn J Clin Oncol (2021)